What changed from existing technology?
This study created a new tool to measure groups of symptoms in Chinese breast cancer patients getting chemotherapy after surgery, using traditional Chinese medicine ideas and expert opinions.
This is the first symptom cluster scale developed specifically for Chinese breast cancer patients undergoing adjuvant chemotherapy, incorporating Traditional Chinese Medicine symptoms and diagnostic information.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 2
velopment of a symptom cluster scale for breast cancer patients undergoing adjuvant chemotherapy based on the Chinese population: a Delphi-based study. Breast
Title ↗specific assessment tools targeting symptom clusters remain scarce, and existing instruments lack characteristics relevant to the Chinese healthcare con
Abstract ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This scale may help clinicians better understand and manage symptom clusters in Chinese breast cancer patients receiving adjuvant chemotherapy, potentially improving patient care and treatment adherence.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.